Ipca Laboratories Ltd gets Form 483 with 11 observations for API manufacturing facility at Ratlam
Ipca Laboratories Limited has announced that the US FDA conducted the inspection of the Company's APIs manufacturing facility situated at Ratlam, Madhya Pradesh from 5th June, 2023 to 13th June, 2023. At the conclusion of the inspection, the US FDA issued a Form 483 with 11 (eleven) observations.<br />
API Manufacturing Facility | 14/06/2023 | By Sudeep Soparkar | 767
Purolite unveils pharma manufacturing facility in King of Prussia, Pennsylvania
The 74,000-square-foot plant will produce ion exchange resins for vital healthcare development and pharmaceutical APIs
API Manufacturing Facility | 06/12/2022 | By Sudeep Soparkar | 265
Lonza begins commercial operations of API manufacturing centre in Nansha, China
The expansion includes six 1,000L reactors, four 1,500L reactors, and isolation equipment providing mid-scale capacity to bridge between early-phase and late-phase production
API Manufacturing Facility | 06/12/2022 | By Sudeep Soparkar | 496
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy